hemodynamic changes in the operative extremity. This study for the first time investigated changes in calf muscle pump function after TKA. The study hypothesis stated improvement in calf muscle pump function after TKA would improve venous health and quality of life for patients.
Methods: This prospective pilot study compared preoperative and postoperative measurements and unilateral patient control in patients undergoing TKA with postoperative follow-up at 1, 2, and 3 months. Clinicians from the Divisions of Vascular Surgery and Orthopedics conducted the study. Demographics including smoking status and CEAP classification were obtained (Table I) . Quality of life was assessed using the Chronic Venous Insufficiency Questionnaire. Preoperative and postoperative Venous Clinical Severity Score, body mass index, leg measurements, and assessment of calf muscle pump function (venous volume, ejection volume, and ejection fraction) using air plethysmography were measured (Table II) Conclusions: Our pilot study indicates, for the first time, a significant improvement in calf muscle pump function, quality of life, and body mass index postoperatively in patients undergoing TKA. This may be attributable to increased range of motion and ambulation, although more investigation is required.
Author Disclosures: K. Hodgson: Nothing to disclose; D. Hood: Nothing to disclose; A. Mitchelson: Nothing to disclose; R. N. Nolte: Nothing to disclose; T. Whitaker: Nothing to disclose. Objectives: Iliac vein stenting is increasingly being used for the treatment of venous insufficiency in patients with nonthrombotic iliac vein lesions. We have noted that many stents do not deploy to the expected area as designated by the manufactured diameter. The purpose of this study was to determine whether certain patient or stent characteristics are associated with stent underexpansion.
IP265.

Underexpansion of Iliac Vein Stents in the Treatment of Venous Insufficiency
Methods: This was a retrospective analysis of all patients treated for iliac vein stenting using Wallstents who did not undergo prestenting or poststenting balloon angioplasty. Multiple linear regression and multiway analysis of variance were performed using R 3.3.2 software to examine the effects of gender, age, stent laterality, location of stenosis, and stent used (grouped based on manufactured dimensions) on the proportion of observed stent area to expected stent area.
Results: There were 210 patients (mean age, 68; range 24-94 years) who underwent 252 treatments at a single center between December 13, 2012, and January 7, 2016, including 78 men (31%) and 174 women (69%). Observations where percentage difference was >200 (n ¼ 6) or where sample size for a given stent was less than three (n ¼ 4) were excluded for a total of 242 analyzed treatments. 90 (47 [19%] ). Stent diameters ranged from 12 to 24 mm. On average, stents deployed to 69.58% of the expected stent area (range, 23.87%-123.35%). Using multiway analysis of variance, the stent used (grouped based on manufactured dimensions) had a significant effect on the proportion of expected stent area achieved (P ¼ .001). Simple linear regression showed a significant negative correlation between increasing stent diameter and percentage of expected stent area achieved (R 2 ¼ 0.068, P < .001). Multiple linear regression detected no significant difference based on age, gender, laterality, specific location of stenosis, or specific stent used.
Conclusions: Although stent used (grouped based on manufactured dimensions) had a significant overall effect on the proportion of expected stent area achieved, there was not enough power in our sample to determine which particular stent produced the significant effect. Further, the significant relationship between increasing stent diameter and degree of stent underexpansion may have implications for future stent designing.
Author Disclosures: E. Ascher: Nothing to disclose; S. N. Blumberg: Nothing to disclose; A. Hingorani: Nothing to disclose; E. Iadagarova: Nothing to disclose; J. Mandel: Nothing to disclose; N. Marks: Nothing to disclose; Y. Ostrozhynskyy: Nothing to disclose.
IP267.
External Jugular Vein Cutdown Approach vs Percutaneous Approach for Totally Implantable Venous Access Device Placement: A Safe, Fast, and Cheap Method Jie Yin, Xiansheng Zhang, Gong Cheng. Peking University First Hospital, Beijing, China
Objectives: External jugular vein (EJV) cutdown for totally implantable venous access device (TIVAD) placement has been accepted as an alternative to the percutaneous subclavian vein approach. The aim of this work was to report a retrospective and monocentric study concerning the feasibility and complications of this surgical technique.
Methods: Patients receiving a TIVAD from January 2010 to December 2015 were included in this study. Age, sex, surgical technique, disease, device used, length of the procedure, and morbidity were considered.
Results: There were 426 TIVADs placed in 418 patients: 149 males (35.6%) and 269 females (64.4%) aged 1 to 73 years. Of 425 patients, 172 underwent an EJV cut down on the first attempt, and 161 (93.6%) procedures were successful. Among the remaining 11 patients, seven (63.6%) underwent a TIVAD placement through the ipsilateral internal jugular vein and through the ipsilateral subclavian vein in the other four. Complications were identified in 11 ports in EJV group (6.25%) and in 35 ports in percutaneous puncture group (14.1%; P < .05).
Conclusions: TIVAD placement by the EJV cutdown approach is safe and fast, and its success rate is very high. By avoiding the immediate complications associated with the percutaneous approach, the EJV cutdown has to be considered a valid, safe.
Author Disclosures: G. Cheng: Nothing to disclose; J. Yin: Nothing to disclose; X. Zhang: Nothing to disclose. 
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